Provided by Tiger Trade Technology Pte. Ltd.

CELLBXHEALTH PLC

0.0670
0.0000
Volume:- -
Turnover:- -
Market Cap:7.61M
PE:-0.08
High:0.0670
Open:0.0670
Low:0.0670
Close:0.0670
52wk High:1.85
52wk Low:0.0666
Shares:113.64M
Float Shares:113.64M
Volume Ratio:4.82
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8699
EPS(LYR):-1.0888
ROE:-87.18%
ROA:-39.98%
PB:0.48
PE(LYR):-0.06

Loading ...

Company Profile

Company Name:
CELLBXHEALTH PLC
Exchange:
OTCQX
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated analysis. It also provides Portrait+ CTC Staining kit, a ready-to-use laboratory kit with high analytical sensitivity and specificity for the identification, characterization, and enumeration of epithelial and mesenchymal transition; and CellKeep Slide, a CTC harvesting technology. In addition, the company offers laboratory services, including enumeration of epithelial and mesenchymal CTC populations; Portrait Flex, an immunofluorescence assay for the identification of epithelial, mesenchymal, and epithelial-to-mesenchymal transition; DNA damage response; Portrait PD-L1, evaluates CTCs; and custom CTC assays. ANGLE plc has a strategic partnership with Bio View Ltd to develop a human epidermal growth factor receptor 2 assay kit for breast cancer; and agreement with NuProbe USA, Inc. to use its proprietary pan-cancer next generation sequencing (NGS) panel. The company was founded in 1994 and is based in Guildford, the United Kingdom.